Syncom Formulations (India)'s Q4 FY 2025-26 Quarterly Results

Result Summary

• Syncom Formulations (India) Ltd reported a 24.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 3.8%.
• Its expenses for the quarter were up by 21.7% QoQ and down 12.3% YoY.
• The net profit increased 33.1% QoQ and increased 42.3% YoY.
• The earnings per share (EPS) of Syncom Formulations (India) Ltd stood at 0.27 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Syncom Formulations (India) Ltd operates in the pharmaceutical manufacturing industry, focusing on the production and distribution of pharmaceutical formulations. The company is known for its diverse range of products, which include tablets, capsules, syrups, and ointments. It caters to both domestic and international markets, leveraging its manufacturing capabilities to meet a wide array of health-related needs. As of the last known updates, Syncom Formulations has been actively involved in expanding its market reach and enhancing its production facilities, although specific recent developments are not available from the data provided.

Revenue

In the fourth quarter of fiscal year 2026, Syncom Formulations (India) Ltd reported a total income of ₹149.97 crores. This represents a significant quarter-over-quarter increase of 24.3% from ₹120.64 crores in the third quarter of fiscal year 2026. However, when compared to the same quarter in the previous fiscal year (Q4FY25), there was a slight decrease in total income by 3.8% from ₹155.82 crores. This fluctuation in revenue highlights the variability in the company's income stream over the periods under review.

Profitability

The company saw considerable growth in its profitability metrics in the fourth quarter of fiscal year 2026. Profit Before Tax (PBT) stood at ₹33.70 crores, marking a 34.3% increase from the previous quarter's ₹25.09 crores and a 44.6% increase from ₹23.30 crores in Q4FY25. The Profit After Tax (PAT) was ₹25.17 crores, which showed a growth of 33.1% quarter-over-quarter from ₹18.91 crores and a year-over-year increase of 42.3% from ₹17.69 crores. The Earnings Per Share (EPS) for this quarter was ₹0.27, reflecting a 17.4% increase from the previous quarter and a notable 68.8% rise from the same quarter last year.

Operating Metrics

Total expenses for the fourth quarter of fiscal year 2026 were reported at ₹116.26 crores, showing a quarter-over-quarter increase of 21.7% from ₹95.55 crores in the third quarter. Compared to the fourth quarter of fiscal year 2025, expenses decreased by 12.3% from ₹132.53 crores. The tax expense for Q4FY26 was ₹8.53 crores, increasing by 38.0% from the previous quarter and 52.0% from the same quarter in the previous year. These operating metrics indicate fluctuations in both expenses and tax obligations, contributing to the overall financial performance of the company during these periods.